Orchid Island Capital Inc. (ORC)
Official siteREAL ESTATE • REIT - MORTGAGE • NYSE
Market Cap: $882.66M
Last updated: Nov 17, 2026 at 11:06 AM ET
Orchid Island Capital Inc. (ORC) Stock Forecast
Analysts expect Orchid Island Capital (ORC) to earn $1.14 per share in the fiscal year ending Dec 31, 2026, on revenue of $237.05M. Of 4 analysts, 0 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 4 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 4 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 14.0% and revenue estimates fall 4.4%.
- Fiscal year ending Dec 31, 2026
- $1.14
- EPS consensus, revenue $237.05M
- Fiscal year ending Dec 31, 2027
- $0.98
- EPS consensus, revenue $226.59M
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.14 | $1.02 to $1.34 | 3 | $237.05M | $235.96M to $238.14M | 2 |
| Dec 31, 2027 | $0.98 | $0.70 to $1.45 | 4 | $226.59M | $160.10M to $288.33M | 3 |
Quarterly Estimates
The EPS consensus falls from $0.27 for the quarter ending Dec 31, 2026 to $0.26 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.27 | $0.22 to $0.36 | 5 | $58.31M | $52.43M to $65.07M | 3 |
| Mar 31, 2027 | $0.26 | $0.19 to $0.36 | 4 | $55.05M | $42.50M to $65.10M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 4 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 2 |
| Fiscal year ending Dec 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.8% from $1.12.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.14 | $1.14 | $1.12 | $1.12 | $1.12 | +2.1% |
| Fiscal year ending Dec 31, 2027 | $0.98 | $1.05 | $1.04 | $1.04 | $1.04 | -5.6% |
| Quarter ending Mar 31, 2027 | $0.26 | $0.26 | $0.29 | $0.29 | $0.29 | -13.1% |
Frequently Asked Questions About ORC
What is the ORC stock forecast?
Consensus analyst estimates put Orchid Island Capital's EPS at $1.14 for the fiscal year ending Dec 31, 2026, on revenue of $237.05M. The consensus rating from 4 analysts is Hold.
How do analysts rate ORC stock?
Of 4 analysts covering Orchid Island Capital, 0 rate it Strong Buy, 0 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from ORC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.14, with estimates from $1.02 to $1.34 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.98, with estimates from $0.70 to $1.45 from 4 analysts.
What revenue do analysts expect from Orchid Island Capital next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $237.05M, with estimates from $235.96M to $238.14M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $226.59M, with estimates from $160.10M to $288.33M.
How many analysts cover ORC?
4 analysts rate Orchid Island Capital stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ORC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors